Business Context and Reporting Period
This Form 8-K is filed by Oculus Innovative Sciences, Inc. (not Sonoma Pharmaceuticals, Inc.) on June 18, 2012. The report addresses a regulatory notice regarding the company's compliance with NASDAQ listing standards.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on stock price compliance rather than financial performance metrics.
Material Changes
- Listing Deficiency: The company received notice from NASDAQ that it failed to maintain the minimum bid price of $1.00 per share for its common stock for the previous 30 consecutive business days.
- Compliance Period: NASDAQ granted the company an initial 180-day compliance period, ending on December 17, 2012, to regain compliance.
- Current Status: The notice has no immediate effect on the listing or trading of the company's common stock.
Outlook, Risks, and Contingencies
- Regaining Compliance: The company may regain compliance at any time during the period if the stock trades at or above $1.00 for ten consecutive business days.
- Delisting Risk: There is no assurance the company will regain compliance. Failure to do so may result in delisting unless the company qualifies for an additional 180-day period.
- Secondary Compliance Path: To qualify for additional time, the company must meet the market value of publicly held shares requirement and all other initial listing standards (excluding bid price), potentially requiring a reverse stock split.
- Forward-Looking Statements: The report includes standard disclaimers that actual outcomes may differ materially from expectations due to various risks.
Investor Verification Checklist
- Verify the current trading price of Oculus Innovative Sciences, Inc. common stock to assess proximity to the $1.00 threshold.
- Monitor the company's stock price performance over the next 10 consecutive business days to determine if immediate compliance is achieved.
- Review the company's market value of publicly held shares to assess eligibility for a second compliance period if the initial deadline is missed.
- Check for any announcements regarding a potential reverse stock split.